-
Cuban tourism in crisis; visitors repelled by fuel, power shortages
-
Liverpool set for Jacquet deal, Palace sign Strand Larsen on deadline day
-
FIFA president Infantino defends giving peace prize to Trump
-
Trump cuts India tariffs, says Modi will stop buying Russian oil
-
Borthwick backs Itoje to get 'big roar' off the bench against Wales
-
Twenty-one friends from Belgian village win €123mn jackpot
-
Mateta move to Milan scuppered by medical concerns: source
-
Late-January US snowstorm wasn't historically exceptional: NOAA
-
Punctuality at Germany's crisis-hit railway slumps
-
Gazans begin crossing to Egypt for treatment after partial Rafah reopening
-
Halt to MSF work will be 'catastrophic' for people of Gaza: MSF chief
-
Italian biathlete Passler suspended after pre-Olympics doping test
-
Europe observatory hails plan to abandon light-polluting Chile project
-
Iran president orders talks with US as Trump hopeful of deal
-
Uncertainty grows over when US budget showdown will end
-
Oil slides, gold loses lustre as Iran threat recedes
-
Russian captain found guilty in fatal North Sea crash
-
Disney earnings boosted by theme parks, as CEO handover nears
-
Sri Lanka drop Test captain De Silva from T20 World Cup squad
-
France demands 1.7 bn euros in payroll taxes from Uber: media report
-
EU will struggle to secure key raw materials supply, warns report
-
France poised to adopt 2026 budget after months of tense talks
-
Latest Epstein file dump rocks UK royals, politics
-
Arteta seeks Arsenal reinforcement for injured Merino
-
Russia uses sport to 'whitewash' its aggression, says Ukraine minister
-
Chile officially backs Bachelet candidacy for UN top job
-
European stocks rise as oil tumbles, while tech worries weigh on New York
-
England captain Itoje on bench for Six Nations opener against Wales
-
Rahm says golfers should be 'free' to play where they want after LIV defections
-
More baby milk recalls in France after new toxin rules
-
Rosenior will not rush Estevao return from Brazil
-
Mercedes ready to win F1 world title, says Russell
-
Germany hit by nationwide public transport strike
-
Barca coach Flick 'not happy' with Raphinha thigh strain
-
WHO chief says turmoil creates chance for reset
-
European stocks rise as gold, oil prices tumble
-
Rink issues resolved, NHL stars chase Olympic gold at Milan
-
S. Korea celebrates breakthrough K-pop Grammy win for 'Golden'
-
Rodri rages that officials 'don't want' Man City to win
-
Gaza's Rafah crossing makes limited reopening after two-year war
-
African players in Europe: Ouattara dents Villa title hopes
-
Liverpool beat Chelsea to Rennes defender Jacquet - reports
-
S. Korea celebrates breakthrough Grammy win for K-pop's 'Golden'
-
Trump says US talking deal with 'highest people' in Cuba
-
Trump threatens legal action against Grammy host over Epstein comment
-
Olympic Games in northern Italy have German twist
-
Bad Bunny: the Puerto Rican phenom on top of the music world
-
Snapchat blocks 415,000 underage accounts in Australia
-
At Grammys, 'ICE out' message loud and clear
-
Dalai Lama's 'gratitude' at first Grammy win
| SCS | 0.12% | 16.14 | $ | |
| CMSC | -0.04% | 23.75 | $ | |
| RIO | 1.4% | 92.325 | $ | |
| CMSD | 0.15% | 24.085 | $ | |
| AZN | -1.86% | 186.965 | $ | |
| RBGPF | 0.12% | 82.5 | $ | |
| BTI | 0.57% | 61.025 | $ | |
| NGG | -1.03% | 84.4 | $ | |
| GSK | 1.42% | 52.345 | $ | |
| BCC | 1.28% | 81.86 | $ | |
| RYCEF | 4.19% | 16.7 | $ | |
| BCE | -0.3% | 25.783 | $ | |
| JRI | 0.53% | 13.15 | $ | |
| RELX | -0.75% | 35.535 | $ | |
| BP | -0.37% | 37.74 | $ | |
| VOD | 1.88% | 14.93 | $ |
Trump-backed panel sows doubt over Covid-19 shots
A Trump-backed health panel questioned Friday the efficacy and safety of Covid-19 vaccines -- and declined explicitly to recommend them -- in an argument some experts said center on "myths" and "anecdotes."
The Advisory Committee on Immunization Practices (ACIP) -- a panel stacked with members handpicked by controversial US health secretary and anti-vaccination advocate Robert F. Kennedy Jr -- said obtaining a Covid-19 shot should be based on individual choice in consultation with a medical professional.
The panel also approved language recommending that the Centers for Disease Control and Prevention urge health care providers to more strongly warn about alleged risks from vaccinations.
Many medical and scientific organizations have cited evidence of the Covid shot's safety and its record of providing strong protection against severe illness or death.
Calling the committee's actions "extraordinarily vague," Sean O'Leary of the American Academy of Pediatrics said "this was like nothing I've ever seen."
"What it looked like to me was a lot of clear efforts to sow distrust in vaccines, to instill fear," he told AFP.
"The focus of a lot of the discussion that we saw today around Covid vaccines was around myths, anecdotes, case series, case reports," O'Leary said. "They were not focused at all on the actual science."
Those comments mirrored criticisms leveled by non-voting observers who attended the meeting.
"It's troubling to see the erosion of the committee's integrity," said Sandra Fryhofer of the American Medical Association.
President Donald Trump's Food and Drug Administration has already narrowed approval for Covid shots -- which all Americans could once get with relative ease -- to the elderly and people with underlying conditions.
That followed Kennedy's spring announcement that the United States would no longer recommend the shots for children and healthy pregnant women.
Public health experts have warned these shifts could muddle access for people seeking boosters both in terms of cost and availability, amid a resurgence in cases and hospitalizations.
The ACIP committee considered whether to require that any person seeking a Covid vaccine first obtain a prescription -- but that measure narrowly failed by a tiebreak vote.
"The segment of the population that is under-insured, has lack of access to health care -- they're going to be unable to get a prescription. And those are the people that are at highest risk," said ACIP member and epidemiologist Catherine Stein in her dissent.
- Confusion -
The ACIP meeting's first day ended in confusion and contradiction. The committee recommended no child under four should receive the combination MMRV shot, which covers measles, mumps, rubella and varicella.
But they also declared that a federal children's vaccine program should still pay for it -- and in a chaotic twist, they reversed that decision in a second vote Friday morning.
Parents will still be offered separate MMR and chicken pox injections for their children younger than four. The combination shot has a small risk of causing temporary, non-life-threatening febrile seizures.
Members also were meant to decide whether to recommend against the longstanding practice of immunizing newborns against Hepatitis B within the first 24 hours of life.
Public health experts have met the prospect of that move with widespread alarm.
Swift vaccination has proven the best way to prevent any maternal transmission of the incurable, highly contagious disease that can cause severe liver damage and cancer later in life, said Adam Langer, a CDC scientist who presented to the voting members.
Ultimately the committee decided more debate was needed.
Many respected members of medical institutions have criticized the redesigned ACIP panel.
"What we're seeing is what happens when individuals who have don't have a basic understanding about how vaccines are delivered are making these crucial policy decisions for the American public," O'Leary said.
D.Schneider--BTB